Table 2.
Orlistat | Nablus | Ramallah | Hebron | |
---|---|---|---|---|
IC 50 μg/mL | 43.64 | 39.81a | 43.73ab | 51.21abc |
| ||||
Antilipase activity | 99.13% | 65.41%a | 54.94%ab | 36.92%abc |
a p < 0.01 compared to Orlistat, bp< 0.01 compared to Nablus sample, and cp< 0.01 compared to Ramallah.